Literature DB >> 7471606

Probenecid-clofibrate interaction.

J R Veenendaal, P M Brooks, P J Meffin.   

Abstract

Clofibric acid disposition was studied in four healthy men after 1 wk of clofibrate ingestion (500 mg orally every 12 hr) with and without probenecid (500 mg orally every 6 hr). Mean (+/- SD) free clofibric acid plasma concentration in the four subjects over a dosage interval at steady state was 2.5 +/- 0.03 mg/1 before and 9.05 +/- 1.09 mg/1 after the probenecid. Probenecid reached an average plasma concentration of 71.3 mg/1. No clofibric acid glucuronide was detected in plasma during either treatment. The fractions of the dose recovered in urine as clofibric acid, clofibric acid glucuronide, and clofibric acid liberated after acid hydrolysis were not altered by probenecid. These data suggest that probenecid causes a reduction in renal and metabolic clearance of clofibric acid, probably as a result of inhibition of the conjugation of clofibric acid with glucuronide.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7471606     DOI: 10.1038/clpt.1981.48

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  8 in total

1.  Reduced elimination of ketoprofen in the elderly is not necessarily due to impaired glucuronidation.

Authors:  R K Verbeeck; S M Wallace; G R Loewen
Journal:  Br J Clin Pharmacol       Date:  1984-06       Impact factor: 4.335

2.  Pharmacokinetics of ketoprofen enantiomers in cholecystectomy patients: influence of probenecid.

Authors:  R T Foster; F Jamali; A S Russell
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

3.  The effects of frusemide and probenecid on the pharmacokinetics of phenprocoumon.

Authors:  H Mönig; M Böhm; E E Ohnhaus; W Kirch
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 4.  Clinical Pharmacokinetics and Pharmacodynamics of Febuxostat.

Authors:  Bishoy Kamel; Garry G Graham; Kenneth M Williams; Kevin D Pile; Richard O Day
Journal:  Clin Pharmacokinet       Date:  2017-05       Impact factor: 6.447

5.  Gender and oral contraceptive steroids as determinants of drug glucuronidation: effects on clofibric acid elimination.

Authors:  J O Miners; R A Robson; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  1984-08       Impact factor: 4.335

6.  The effect of probenecid on paracetamol metabolism and pharmacokinetics.

Authors:  F Kamali
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

7.  Effect of probenecid on the formation and elimination kinetics of the sulphate and glucuronide conjugates of diflunisal.

Authors:  J I Macdonald; S M Wallace; R J Herman; R K Verbeeck
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

8.  Effect of probenecid on isofezolac kinetics.

Authors:  A Bannier; F Comet; J Soubeyrand; J L Brazier; F Chauliac
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.